CAPITAL FUND MANAGEMENT S.A. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPITAL FUND MANAGEMENT S.A. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$404,362
-100.0%
11,314
-50.9%
0.00%
-75.0%
Q3 2022$1,018,307,000
-29.7%
23,023
-41.1%
0.01%
-38.5%
Q2 2022$1,447,852,000
-12.6%
39,110
-12.5%
0.01%
-7.1%
Q1 2022$1,656,391,000
+93.7%
44,719
+59.1%
0.01%
+133.3%
Q4 2021$855,326,000
-24.2%
28,108
+18.2%
0.01%
-57.1%
Q3 2020$1,128,503,000
+72008.8%
23,783
-28.2%
0.01%
-41.7%
Q1 2020$1,565,000
-59.6%
33,111
-48.3%
0.02%
-22.6%
Q4 2019$3,871,000
+14.6%
64,088
+13.6%
0.03%
+3.3%
Q3 2019$3,379,000
-48.3%
56,406
-44.5%
0.03%
-49.2%
Q2 2019$6,533,000
+87.9%
101,649
+137.4%
0.06%
+90.3%
Q1 2019$3,476,000
+220.7%
42,821
+103.7%
0.03%
+416.7%
Q3 2018$1,084,000
+300.0%
21,024
+242.4%
0.01%
+200.0%
Q1 2018$271,000
-82.2%
6,140
-79.6%
0.00%
-81.8%
Q3 2017$1,523,000
-65.6%
30,038
-65.5%
0.01%
-69.4%
Q2 2017$4,432,000
+2105.0%
87,120
+1974.3%
0.04%
+1700.0%
Q4 2016$201,000
-70.6%
4,200
-77.5%
0.00%
-66.7%
Q3 2016$683,000
-69.7%
18,638
-80.7%
0.01%
-71.4%
Q2 2016$2,252,000
-63.8%
96,664
-37.0%
0.02%
-65.6%
Q1 2016$6,215,000
-23.5%
153,486
+17.0%
0.06%
-27.4%
Q4 2015$8,121,000131,1480.08%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,136$133,7497.12%
Bellevue Group AG 9,743,900$368,027,1034.88%
M28 Capital Management LP 126,300$4,770,3514.55%
Sicart Associates LLC 246,258$9,301,1653.28%
Camber Capital Management LP 1,925,000$72,7072.49%
Privium Fund Management B.V. 148,807$5,557,9412.11%
Deep Track Capital, LP 1,205,773$45,542,0461.91%
BVF INC/IL 1,121,809$42,370,7261.79%
Orbimed Advisors 1,993,600$75,298,2721.44%
Parkman Healthcare Partners LLC 141,115$5,329,9141.42%
View complete list of IONIS PHARMACEUTICALS INC shareholders